US Equity
REPL
— REPLIMUNE GROUP, INC.Replimune Group, Inc. is a clinical-stage biotechnology company that develops oncolytic immunotherapies using its proprietary HSV-based platform for cancer treatment.
💰 Market cap: $724.45M📍 500 Unicorn Park Dr, WOBURN, MA, 01801-3377 US🏷️ Biotechnology & Medical Research💵 Previous close: $9.70🔢 9,876 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-27 | $8.63 |
| 2026-07-24 | $9.70 |
| 2026-07-23 | $10.46 |
| 2026-07-22 | $10.75 |
| 2026-07-21 | $11.00 |
| 2026-07-20 | $10.51 |
| 2026-07-17 | $10.23 |
| 2026-07-16 | $9.52 |
| 2026-07-15 | $9.68 |
| 2026-07-14 | $9.87 |
| 2026-07-13 | $9.94 |
| 2026-07-10 | $10.99 |
| 2026-07-09 | $11.11 |
| 2026-07-08 | $11.12 |
| 2026-07-07 | $11.51 |
| 2026-07-06 | $11.47 |
| 2026-07-02 | $11.58 |
| 2026-07-01 | $11.22 |
| 2026-06-30 | $11.07 |
| 2026-06-29 | $11.20 |
| 2026-06-26 | $11.63 |
| 2026-06-25 | $11.13 |
| 2026-06-24 | $11.27 |
| 2026-06-23 | $11.42 |
| 2026-06-22 | $11.18 |
| 2026-06-18 | $10.19 |
| 2026-06-17 | $10.00 |
| 2026-06-16 | $8.78 |
| 2026-06-15 | $8.96 |
| 2026-06-12 | $8.88 |
| 2026-06-11 | $8.62 |
| 2026-06-10 | $8.47 |
| 2026-06-09 | $9.24 |
| 2026-06-08 | $8.97 |
| 2026-06-05 | $9.47 |
| 2026-06-04 | $9.87 |
| 2026-06-03 | $9.98 |
| 2026-06-02 | $8.87 |
| 2026-06-01 | $9.00 |
| 2026-05-29 | $8.69 |
| 2026-05-28 | $4.68 |
| 2026-05-27 | $4.70 |
| 2026-05-26 | $4.60 |
| 2026-05-22 | $4.91 |
| 2026-05-21 | $5.22 |
| 2026-05-20 | $5.16 |
| 2026-05-19 | $4.70 |
| 2026-05-18 | $5.01 |
| 2026-05-15 | $5.22 |
| 2026-05-14 | $4.93 |
| 2026-05-13 | $5.30 |
| 2026-05-12 | $4.09 |
| 2026-05-11 | $3.74 |
| 2026-05-08 | $4.07 |
| 2026-05-07 | $3.34 |
| 2026-05-06 | $3.44 |
| 2026-05-05 | $2.87 |
| 2026-05-04 | $3.03 |
| 2026-05-01 | $2.50 |
| 2026-04-30 | $2.57 |
| 2026-04-29 | $2.38 |
| 2026-04-28 | $2.57 |